Eric Lefkofksy: Gathering Large Scale Data for Better Cancer Research and Treatment Outcomes

Eric Lefkofsky is a social entrepreneur with a background in innovation and technological design. He has started multiple e-commerce giants and is now focused on medical research and infrastructure. His latest endeavor, Tempus, is focused on treating cancer patients. By gathering data on a larger scale its possible to get enough molecular data to guide the development of cancer treatments. Massive genome research can inform the way physicians treat patients and in the establishment of patterns and trends in patient data.

Eric Lefkofsky explains that many research institutes are sequencing genome information and gathering patient data. However, these collection efforts are not at scale when compared to the great number of people who are affected by cancer.

Gaining access to big data is one way that not-for-profits and research institutes can leverage genetic information in the development of new drugs and treatment procedures. For example, Venter Institute And IBM have determined a similar need for large-scale data when it comes to creating effective treatment procedures for complex diseases. Because of the lower costs of genetic screening and data storage, it’s important for this information base to continue to grow and develop in relation to cancer treatment.

Tempus stands out from the rest because of their broad scale objectives. Their partnerships are expected to involve medical centers, universities and research centers to get a large pool of data. This would allow for larger scale patterns to be identified and potential genetic information to lead to better clinical practices. Eric Lefkofksy compares Tempus to other ventures, in that all endeavors have a component of Big Data. Understanding how organizations leverage data collection to come up with effective solutions and strategies is an important way to get ahead when it comes to cancer related research. To know more about him click here.

Further research of this institution will provide gene sequencing tests and incorporate much needed software in the process. By establishing cumulative ways to collect patient information it will be possible to come up with better analysis and methods of incorporating findings in targeted therapies. These are some of the ways that Tempus Labs serves a need in the community to improve outcomes when treating cancer patients.

An in depth look at Dr. Mark McKenna

Dr. Mark McKenna is an Medical Doctor that currently is licensed to practice medicine in Florida as well as Georgia. Not only is Mark McKenna devoted to his profession, he is also dedicated to serving many charitable causes throughout his community.

Dr. McKenna Graduated from Tulane University Medical School. Tulane University is located in New Orleans Louisiana. He graduated Medical School with top honors.

Mark McKenna made an easy choice to practice medicine along side his father whom is also a Physician. Therefore, Mark McKenna practiced medicine in his fathers practice and still pursued other interests within his free time. McKenna always had an interest in real-estate. He created his own real-estate organization in which he called McKenna Venture Investments. Aside from practicing medicine, Dr. Mark McKenna ran his own real-estate investment firm and he did quite well within the first year.

McKenna Venture Investments became a successful establishment within a five year period. This gave McKenna even more incentive to explore his ambitions. Therefore, Mark McKenna also established another organization which was called Universal Lending Company. Universal offered efficient and reliable mortgage and real-estate closing services.

After a great deal of success at a young age, Mark McKenna relocated ten years ago and launched yet another company.

In early 2017, Mark McKenna became the CEO of an organization called “OVME”. OVME was a technology and medical based company that also specialized in elective type medical care. However, the organization made subsequent changes for the better within the elective medical/health care arena. To date, Dr. Mark McKenna remains CEO of OVME. He has made many changes that hopefully will affect the health care industry in a positive fashion. One specific area of focus for Dr. McKenna at present is making health care affordable and accessible to all those in need.

Mark McKenna is grateful for success at an early age. However, there is still a great deal that he wishes to do in order to make a difference in a very difficult world. McKenna shows great concern for the young who are just starting out attempting to establish themselves in a successful business or profession.